Leveraging The Power Of AI
Najat Khan, PhD, chief data science officer and global head, strategy, portfolio & operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson shares her career path and how she became interested in clinical data. She also discusses some current trends in artificial intelligence/machine learning such as utilizing them in drug discovery and making clinical trials more inclusive.
26m Sep 19, 2023
26m
A Look at the Current State of Sites
Jimmy Bechtel, MBA, vice president of site engagement for the Society of Clinical Research Sites (SCRS) discusses his career path and how he became so interested in clinical trial sites. He also addresses some of the most pressing challenges sites are currently seeing as well as the solutions SCRS is working on to address them.
25m Sep 05, 2023
25m
Where Digital Health Technology Intersects With Pharma
Chris Economos, Vice President and Head of Life Sciences at Eko, discusses his career journey from pharma to digital health technology, where he recognized the power of AI and digital health to improve clinical care and research. He discusses the current ability of AI in the future use of digital measurements and biomarkers to improve clinical trials, as well as outcomes.
20m Aug 22, 2023
20m
AI Is The New Electricity
Michael Ibara, Chief Data Officer, Elligo Health Research, discusses the history of mining healthcare data and using it to identify safety events, as well as the evolution of bringing EHR data closer to the clinical research worlds. He also touches on the implications of AI—comparing its fundamental impact as “the new electricity”—and its potential uses for clinical trials, regulatory, and the ...
23m Aug 08, 2023
23m
Building Clinical Trials With Trust
Charlotte Grayson, MD, clinical research medical director, Privia Health highlights her journey to becoming a physician and eventually getting involved with clinical trials. She also discusses what integrated research organizations (IROs) are now bringing to the table and how they are effective in enrollment and building patient-physician relationships.
14m Jul 25, 2023
14m
The Evolution of Early-phase Research
Colleen Hoke, Co-Founder and CEO of ObjectiveHealth discusses her career in early-phase research and the transition from working with a startup to a major research organization. She also touches on what her current company, ObjectiveHealth is working on, leadership skills, and the evolution of clinical research.
20m Jul 11, 2023
20m
The Trust Factor In Data
Craig Serra, Head of Commercial Solutions and Partnerships at Flatiron Health’s Clinical Research Business Unit, discusses data and its many uses in clinical trials that guide operational decision-making; how the people in that work in clinical trials make the difference and how to bring the next generation up in clinical trials.
16m Jun 27, 2023
16m
Addressing The Gap Between Tech In Every Day Life Vs. Tech In Clinical Trials
Jennifer Duff, General Manager, Zelta Clinical Trials Solutions, Merative (formerly IBM Watson Health), discusses her leadership philosophy, the number of name changes and product mergers her company has gone through, major technological changes are impacting clinical trials operations professionals today and in the future, plus much more.
17m Jun 13, 2023
17m
Cell And Gene Therapy: Still On A Learning Curve
Chris Learn, PhD, PMP, Vice President, Cell and Gene Therapy Center of Excellence, Parexel describes highlights of his career, what originally spurred his interest in clinical research, the current landscape of CGTs and much more.
9m May 30, 2023
9m
Clinical Studies Take Teamwork
Doug Warner, MD and CMO for eFFECTOR Therapeutics, a clinical stage biopharma targeting oncology, discusses the complexities of oncology clinical trials, bringing his career-long learnings with Amgen to his current role, and the important relationship medical directors should have with their clinical study teams.
21m May 16, 2023
21m
Drug Development Agility with Safety First
Peter Benton, President and CO-CEO for Worldwide Clinical Trials, leads a diverse team of more than 3,000 people in more than 60 countries. Benton speaks about his unconventional entrance into the pharmaceutical industry, advice for clinops professionals, significant changes coming for industry, and much more.
24m May 02, 2023
24m
Examining the Neurology/Neuromuscular Space
In this episode of the Applied Clinical Trials podcast, we are joined by Sindhu Ramchandren, MD, Director, Clinical Leader, Neuroscience at Janssen. With experience as a principal investigator on neuromuscular trials, Ramchandren discusses the importance of having physicians involved in clinical trials. She also walks us through her career path and gives insight into her work on finding potenti...
14m Apr 18, 2023
14m
Data In Clinical Trials—How Did We Get Here And What’s Next?
Gabriele Brambilla, CEO of Alira Health, discusses the ever-evolving landscape of real-world data; more specifically, how data sharing in clinical research should be implemented to value the person. He also highlights his career path and how he became so interested in healthcare innovation.
16m Apr 04, 2023
16m
Health Equity In Clinical Trials
Rose Blackburne, MD, MBA, Vice President, Global Head, General Medicine, PPD Clinical Research, Thermo Fisher and Margarita Nunez, MD, Principal Investigator, Synexus NY / Accelerated Enrollment Solutions New York discuss their panel at the recent Health Equity in Clinical Trials Congress in Boston last month; share insights into how diversity can be improved at the site and CRO; and the hope t...
34m Mar 21, 2023
34m
Treat Disease, Not the Symptoms
In this podcast, Dr. Ira Spector discusses how his career journey has epitomized the ability to solve problems, which is essentially the role of drug development. It has also led to the formation and strategic approach to his company’s early-stage clinical trials for using the microbiome to address chronic inflammatory diseases.
26m Mar 07, 2023
26m
A Passion For Pharmacovigilance- Keeping Patients Safe
Beth MacEntee Pileggi, Head of Global Case and Safety Data Management with Janssen Pharmaceuticals of Johnson & Johnson, and Co-Lead of TransCelerate’s Pharmacovigilance Agreements Optimization Initiative, discusses the importance of safety, collaboration, TransCelerate’s positive role in the pharma industry and her passion for PV.
27m Feb 21, 2023
27m
The Rewarding Path Of Science
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
14m Feb 07, 2023
14m
IndoUSrare: Purposeful Clinical Research For Rare Diseases In India
Dr. Harsha Rajasimha, Founder and Chairman of IndoUSrare, discusses the emotional reason behind founding the non-profit, programs they offer that are helping rare disease parents/patients, rare disease research in India, and much more.
31m Jan 24, 2023
31m
Patient Recruitment Strategies In A True Digital Age
Dan Brenner, Founder and CEO of 1nHealth, discusses his path into clinical research and patient recruitment, the Gold Eagle Next Generation Board, what millennials/next generations want from organizations they buy from or invest in, how industry can best harness patient data to accurately predict recruitment timelines, and much more.
23m Jan 10, 2023
23m
Sandy Milligan, MD, JD, Head Of Research And Development, Organon
In this podcast, Dr. Milligan makes the case for studying drugs in pregnant and lactating women on an ongoing basis to understand long-term efficacy and safety, as well as effects of concomitant medications on these women. Sandy believes that the entire ecosystem--regulators, policymakers, governments, physicians, healthcare systems, and industry, need to have a conversation around improving th...
18m Dec 06, 2022
18m
The Key To Innovation In Clinical Research? Listening.
Jane Myles, Vice President, Clinical Trial Innovation at Curebase, discusses her current role, what led her there, and challenges their clients face with DCTs.
24m Nov 29, 2022
24m
The Ins and Outs of Digital Twins
Chief Science Officer at Unlearn.AI, Dave Miller, discusses digital twins, their pros and cons for the industry, and developments in Bayesian design and adaptive trials for CDER and CBER.
12m Nov 15, 2022
12m
Advantages of Precision Endpoints
Susan Wood, president and CEO of VIDA Diagnostics, discusses her journey into healthcare from an engineering path, changes in the field of imaging, virtual control arms, and much more
21m Nov 01, 2022
21m
A Passion For Sourcing
Todd Luckritz, Associate Director, Patient Solutions at Myonex, recently left Mayo Clinic as the lead pharmacist for its clinical research programs. In this podcast, Luckritz discusses his journey “bringing protocols to life,” the joy of interacting with patients, and the frustrations with sourcing that led him to make a difference at Myonex. To learn more about Myonex, sign up for their on-de...
11m Oct 18, 2022
11m
Long-Time Clinical Trials Exec Looks Back And Forward
Paula Brown Stafford, CEO of Novan, came to her role via increasing clinical development role responsibilities with Quintiles, now IQVIA. In this podcast, she reflects on her professional experiences, her achievements and her advice for clinical trials professionals.
9m Oct 04, 2022
9m
The Oncologist:Patient Conversation Must Include Clinical Trials
Dr. Shalaan Beg, VP of Oncology for Science 37, discusses his approach to reducing the time to trial activation at an NCI designated cancer center, how to ensure a diverse representation in clinical trials, and his opinion on decentralized and hybrid trials.
28m Sep 20, 2022
28m
Pioneers In Patient Data Capture
Christine McSherry, CEO of Casimir and Mindy Leffler, President and Chairman of Casimir, now a part of CRO Emmes, discuss their path to true patient focused drug development based on their experiences raising sons with Duchenne Muscular Dystrophy (DMD). By understanding early and actual measurable endpoints that matter to DMD patients and caregivers, and providing PROs that can capture data tha...
38m Sep 06, 2022
38m
SMO, A Model Sustained By Necessity
Dr. Ian Smith MBE MB ChB.B MedSc(Hons), Founder, Director and Chief Medical Officer of Panthera Biopartners, and Chris Dodd, the company's Chief Commercial Officer, discuss the evolution of the Site Management Organization and Panthera Biopartners, how clinical trials remain mired in underperformance and difficulties, and hybrid trial advancements.
20m Aug 23, 2022
20m
Meeting People Where They Are
Praduman “PJ” Jain, CEO & Founder, Vibrent Health; Principal Investigator, NIH All of Us Research Program, Participant Technology Systems Center; Principal Investigator, NIH RADx Program, discusses his involvement in the NIH All of Us program, digital health research tools, and more.
23m Aug 09, 2022
23m
Breaking Barriers Inside and Outside of Clinical Trials
Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses the key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.
22m Jul 26, 2022
22m
Diversity in Clinical Trials—It Takes a Village
Catharine Grimes, Senior Director, Bristol Myers Squibb Foundation, discusses the goal to increase diversity in clinical trials through the BMS Foundation Diversity in Clinical Trials Career Development Award Program, the Foundation's Global Cancer Disparities Initiative, and more. Listen to the latest Pharmaceutical Commerce podcast: bit.ly/3uyWD8d
13m Jul 12, 2022
13m
Linking Healthcare and Clinical Trials with Sensors
Kuldeep Singh Rajput, CEO and founder of Biofourmis, with over 10 years of experience in the biomedical space continues to work alongside a previous guest of the ACT Podcast, Jyadev Thakkar, on electronic and biosensing research and products, including wearable solutions and biosignal analytics for cardiac health monitoring.
13m Jun 28, 2022
13m
Hope, Hype, Happening: Our Current Era of Clinical Trials
Mike Keens, VP of Operations at Anju Software, offers his insights into the current state of decentralized trials, the state of clinical trials technology and the near-future skill sets for clinical trials professionals.
22m Jun 14, 2022
22m
Interoperability At Work
Ardy Arianpour, Founder and CEO of Seqster, discusses his experience launching and establishing a company’s presence through COVID, acceptance of digital and data use in the industry, and recently joining the DTRA. Check out Ardy's episode of the Pharmaceutical Commerce Podcast, here: https://www.pharmaceuticalcommerce.com/view/seeking-better-patient-engagement
18m May 31, 2022
18m
The Need For Pediatric Clinical Trials and Data
Dr. Salim Idriss, Executive co-director of the Duke Pediatric and Congenital Heart Center & director of pediatric electrophysiology at Duke University Medical Center discusses a collaboration with the Cardiac Safety Research Consortium (CSRC), the FDA, and Duke University Medical school.
26m May 17, 2022
26m
Industry Updates From the Road
Associate editor, Andy Studna, talks with Editorial Director, Lisa Henderson, about her recent travels to various industry conferences, the insights she gained from them, and a review/preview of recent issues.
15m May 03, 2022
15m
What Academic Research and Industry Can Learn From Each Other
Pamela B. Davis, MD, PhD, Professor of General Medical Sciences at Case Western Reserve University School of Medicine and Member of the Board of Directors for the Clinical Research Forum, discusses the clinical research industry, her own career, and the article that Dr. Davis and her colleague, Dr. Wu, wrote for Applied Clinical Trials. Read the article here: https://www.appliedclinicaltrialson...
24m Apr 19, 2022
24m
A Passion for Predictions
Mike Rousselle, Vice President of Data Product for OptimizeRx, discusses his serendipitous career, current role, how the company ties AI and RWE together for trial recruitment, and more.
24m Apr 05, 2022
24m
EMR to CTMS That Works for Trialists
Jason Baumgartner, Founder and CEO of BEKHealth—an EMR to CTMS platform that uses EMR data to find patients and integrate them into the CTMS process—talks about EMR structured and unstructured data, his own career, and some additional background on BEKHealth.
20m Mar 22, 2022
20m
The State of CRO Employment
Judy Canavan, Managing Director and Leader at BDO, Compensation and Benefits practice, discusses how BDO collects the data for its CRO Industry Global Compensation & Turnover Survey, recent calls for CROs to invest in their HR departments, and the effect of the Great Resignation on the industry.
18m Mar 08, 2022
18m
Clinical Trials Separate the Signal from the Noise
Avi Kulkarni, Senior Vice President, Research & Development, at Cognizant, discusses the trajectory and growth of the Shared Investigator Platform; the history and impact of biomarkers in clinical trial conducts, as well as personal insights from his 30-year career.
26m Feb 22, 2022
26m
ClinOps, Follow the Science
Kimberly Gentile, Senior VP, Clinical Operations for Biohaven Pharmaceuticals, discusses her current position for a company that currently has a lot going in the Phase III space, as well as how her unique career journey lead her to this moment.
20m Feb 08, 2022
20m
Oncologists’ Insights on Clinical Trials
Dr. C.K. Wang, Chief Medical Officer for COTA discusses the use of real world data, the results of a recent survey by COTA, and his own career journey. Read the study results, here: Oncologist survey: https://cotahealthcare.com/study-83-of-oncologists-believe-real-world-data-is-critical-to-accelerating-cancer-research-and-treatment/ Patient survey: https://cotahealthcare.com/study-cancer-pati...
16m Jan 25, 2022
16m
Data Aggregation and AI in Use Today
Martin Gouldstone, Chief Business Officer of Life Sciences, Sensyne, updates us on the status of AI in data used for clinical research, the difference between ethical AI vs. AI, and what Sensyne is trying to achieve in this space.
25m Jan 11, 2022
25m
SCOPE Preview: ClinOps Education And Networking
Micah Lieberman, Executive Director, Conferences for CHI and Co-Founder, VP, Community and Business Development of ClinEco talks about what to expect at the upcoming SCOPE conference in February, tips on how to get the most out of your experience, life during the pandemic, and much more.
39m Dec 20, 2021
39m
Academia to Industry: Insights from Amgen’s Executive Medical Director
Jane Parnes, Executive Medical Director, Early Development at Amgen talks about her own career path, how clinical trials are being conducted at Amgen, as well as her experience as a female leader in STEM.
25m Dec 14, 2021
25m
A Resource for Connecting Patients to Trials
Jenny Ahlstrom, founder of the HealthTree Foundation, discusses their community for AML and myeloma patients, how they help their patients navigate clinical trials, how their portal seamlessly gets patients records to researchers, and how industry can utilize their resources and engage with patients.
34m Nov 30, 2021
34m
Patient Advocacy in All Areas of Drug Development
Dr. Lise Lund Kjems, Chief Medical Officer at Cyclo Therapeutics, talks about Cyclo’s investigational therapy for Niemann-Pick Disease Type C and gives insight into rare disease drug development, with an emphasis on ensuring trial design includes holistic and specific patient concerns.
28m Nov 16, 2021
28m
The Life of a Quality Professional
Bob Chaplinsky, Director Corporate Quality Compliance at UCB, discusses the trajectory of quality management systems in pharma, the importance of change management when implementing new systems, and staying on top of compliance and regulatory changes on a global scale.
13m Nov 02, 2021
13m
Keeping Sites at the Center of Clinical Research
Mary Costello, Head of Site and Investigator Network at Medable, and Pat Larrabee, CEO of Rochester Clinical Research, discuss their extensive careers in the clinical trials industry, as well as talk about their article in our October issue, “Why Siteless Trials Won’t Work.”
28m Oct 19, 2021
28m